loadpatents
name:-0.050696849822998
name:-0.018259048461914
name:-0.0074541568756104
Tanzi; Rudolph E. Patent Filings

Tanzi; Rudolph E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tanzi; Rudolph E..The latest application filed is for "methods of treating cytokine release syndrome".

Company Profile
6.18.41
  • Tanzi; Rudolph E. - Milton MA
  • Tanzi; Rudolph E. - Hull MA
  • TANZI; Rudolph E. - Cohasset MA
  • Tanzi; Rudolph E. - Charlestown MA
  • Tanzi; Rudolph E. - Canton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Treating Cytokine Release Syndrome
App 20220218652 - Elmaleh; David R. ;   et al.
2022-07-14
Macrophages/microglia In Neuro-inflammation Associated With Neurodegenerative Diseases
App 20220079914 - Elmaleh; David R. ;   et al.
2022-03-17
Potent gamma-secretase modulators
Grant 11,117,884 - Wagner , et al. September 14, 2
2021-09-14
Screening Platform To Identify Therapeutic Drugs Or Agents For Treatment Of Alzheimer's Disease
App 20200206187 - TANZI; Rudolph E. ;   et al.
2020-07-02
Tau Phosphorylation Inhibitors And Methods For Treating Or Preventing Alzheimer's Disease
App 20200121666 - WONG; Stephen T.C. ;   et al.
2020-04-23
Potent Gamma-secretase Modulators
App 20200055840 - Wagner; Steven L. ;   et al.
2020-02-20
Potent gamma-secretase modulators
Grant 10,472,346 - Wagner , et al. Nov
2019-11-12
Macrophages/microglia In Neuro-inflammation Associated With Neurodegenerative Diseases
App 20190240194 - Elmaleh; David R. ;   et al.
2019-08-08
Gamma-secretase modulators
Grant 9,938,263 - Tanzi , et al. April 10, 2
2018-04-10
Potent Gamma-secretase Modulators
App 20180093967 - Wagner; Steven L. ;   et al.
2018-04-05
Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
Grant 9,403,815 - Wagner , et al. August 2, 2
2016-08-02
Gamma-secretase Modulators
App 20160024073 - TANZI; Rudolph E. ;   et al.
2016-01-28
Antibodies To Cross-linked Amyloid Beta Oligomers
App 20150218259 - Moir; Robert ;   et al.
2015-08-06
Antibodies To Cross-linked Amyloid Beta Oligomers
App 20140377267 - Moir; Robert ;   et al.
2014-12-25
Compounds And Uses Thereof In Modulating Levels Of Various Amyloid Beta Peptide Alloforms
App 20130165416 - Wagner; Steven L. ;   et al.
2013-06-27
Regulation Of Bace Degradation
App 20130022994 - Tanzi; Rudolph E. ;   et al.
2013-01-24
Regulation of BACE degradation
Grant 8,273,543 - Tanzi , et al. September 25, 2
2012-09-25
Antibodies To Cross-linked Amyloid Beta Oligomers
App 20120114635 - Moir; Robert ;   et al.
2012-05-10
Antimicrobial Compositions And Methods Of Use Therefore
App 20120058935 - Moir; Robert ;   et al.
2012-03-08
Regulation Of Bace Degradation
App 20110177543 - TANZI; RUDOLPH E. ;   et al.
2011-07-21
Reduction Of Beta-amyloid Levels By Treatment With The Small Molecule Differentiation-inducing Factor
App 20100311726 - Myre; Michael ;   et al.
2010-12-09
Measurement of GGA proteins for diagnosing BACE associated disease
Grant 7,781,177 - Tanzi , et al. August 24, 2
2010-08-24
Prevention And Treatment Of Post-operative Cognitive Dysfunction
App 20100113570 - Xie; Zhongcong ;   et al.
2010-05-06
Regulation of BACE degradation
App 20080118499 - Tanzi; Rudolph E. ;   et al.
2008-05-22
Methods for identifying compounds that modulate stabilization of secretase-associated proteins
Grant 7,326,540 - Tanzi , et al. February 5, 2
2008-02-05
Methods for reducing amyloid beta levels
App 20060172964 - Tanzi; Rudolph E. ;   et al.
2006-08-03
Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
Grant 7,045,531 - Bush , et al. May 16, 2
2006-05-16
Use of clioquinol for the therapy of alzheimer's disease
App 20060074104 - Bush; Ashley I. ;   et al.
2006-04-06
Methods and compositions relating to modulating amyloid precursor protein cleavage
App 20050170437 - Puglielli, Luigi ;   et al.
2005-08-04
Methods for treating ACAT-related diseases
App 20050118226 - Kovacs, Dora M. ;   et al.
2005-06-02
Method of screening for drugs useful in treating Alzheimer's disease
App 20050112543 - Bush, Ashley I. ;   et al.
2005-05-26
Diagnostic assay for Alzheimer's disease: assessment of A.beta. abnormalities
Grant 6,890,727 - Tanzi , et al. May 10, 2
2005-05-10
Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
Grant 6,887,983 - Tanzi , et al. May 3, 2
2005-05-03
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
App 20050009031 - Becker, Kenneth David ;   et al.
2005-01-13
Methods and compositions for diagnosing, preventing, and treating Alzheimer's disease
App 20040219610 - Tanzi, Rudolph E. ;   et al.
2004-11-04
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
App 20040067512 - Becker, Kenneth David ;   et al.
2004-04-08
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
App 20030224380 - Becker, Kenneth David ;   et al.
2003-12-04
Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
Grant 6,638,711 - Bush , et al. October 28, 2
2003-10-28
Chromosome 1 gene and gene products related to alzheimer's disease
App 20030180880 - Tanzi, Rudolph E. ;   et al.
2003-09-25
Genetic markers for Alzheimer's disease and methods using the same
App 20030170678 - Tanzi, Rudolph E. ;   et al.
2003-09-11
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
App 20030162202 - Becker, Kenneth David ;   et al.
2003-08-28
Diagnostic Assay For Alzheimer's Disease: Assessment Of Ab Abnormalities
App 20030073074 - TANZI, RUDOLPH E. ;   et al.
2003-04-17
.alpha.-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
Grant 6,472,140 - Tanzi , et al. October 29, 2
2002-10-29
Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease
App 20020114792 - Tanzi, Rudolph E. ;   et al.
2002-08-22
In vitro system for determining formation of abeta amyloid
App 20020115223 - Tanzi, Rudolph E. ;   et al.
2002-08-22
Purified 20 Kda Presenilin 2 C-terminal Fragment And Methods Of Screening For Compounds That Inhibit Proteolysis Of Presenilin 2
App 20020086444 - TANZI, RUDOLPH E. ;   et al.
2002-07-04
Agents for use in the treatment of alzheimer's disease
App 20020082273 - Bush, Ashley I. ;   et al.
2002-06-27
Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's disease
App 20020028462 - Tanzi, Rudolph E. ;   et al.
2002-03-07
Use of clioquinol for the therapy of Alzheimer's disease
App 20020025944 - Bush, Ashley I. ;   et al.
2002-02-28
Method for treatment of neurodegenerative diseases
App 20020015941 - Kim, Tae-Wan ;   et al.
2002-02-07
Agents for use in the treatment of Alzheimer's disease
Grant 6,323,218 - Bush , et al. November 27, 2
2001-11-27
Modulators of expression and function of LRP in alzheimer's disease
Grant 6,156,311 - Strickland , et al. December 5, 2
2000-12-05
Isolation and uses of a Wilson's disease gene
Grant 6,068,975 - Gilliam , et al. May 30, 2
2000-05-30
Methods for modulating transcription from the amyloid .beta.-protein precursor (APP) promoter
Grant 5,643,726 - Tanzi , et al. July 1, 1
1997-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed